High Potency of Melaleuca alternifolia Essential Oil against Multi-Drug Resistant Gram-Negative Bacteria and Methicillin-Resistant Staphylococcus aureus
- PMID: 30304862
- PMCID: PMC6222846
- DOI: 10.3390/molecules23102584
High Potency of Melaleuca alternifolia Essential Oil against Multi-Drug Resistant Gram-Negative Bacteria and Methicillin-Resistant Staphylococcus aureus
Abstract
Purpose: Herein, an extended investigation of Tea tree oil (TTO) against a number of multi-drug resistant (MDR) microorganisms in liquid and vapor phases is reported.
Methods: The activity of TTO was tested against methicillin-sensitive Staphylococcus aureus (MSSA), Escherichia coli, and clinical strains of methicillin-resistant S. aureus (MRSA), extended-spectrum beta lactamases producer carbapenem-sensitive Klebsiella pneumoniae (ESBL-CS-Kp), carbapenem-resistant K. pneumoniae (CR-Kp), Acinetobacter baumannii (CR-Ab), and Pseudomonas aeruginosa (CR-Pa). Minimal inhibitory/bactericidal concentrations (MIC/MBCs) and synergistic activity between TTO and different antimicrobials were determined. In the vapor assay (VP), TTO-impregnated discs were placed on the lid of a petri dish and incubated for 24 h at 37 °C.
Results: TTO showed a potent bactericidal activity against all the tested microorganisms. TTO in combination with each reference antimicrobial showed a high level of synergism at sub-inhibitory concentrations, particularly with oxacillin (OXA) against MRSA. The VP assay showed high activity of TTO against CR-Ab.
Conclusion: Evaluation of in-vitro activity clearly indicated TTO as a potential effective antimicrobial treatment either alone or in association with known drugs against MDR. Therefore, TTO could represent the basis for a possible role in non-conventional regimens against S. aureus and Gram-negative MDR. TTO in VP might represent a promising option for local therapy of pneumonia caused by CR-Ab.
Keywords: Melaleuca alternifolia; carbapenem-resistant microorganisms; essential oils; methicillin-resistant Staphylococcus aureus; multi-drug resistant bacteria.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Changes in antibiotic susceptibility in staphylococci habituated to sub-lethal concentrations of tea tree oil (Melaleuca alternifolia).Lett Appl Microbiol. 2008 Oct;47(4):263-8. doi: 10.1111/j.1472-765X.2008.02420.x. Lett Appl Microbiol. 2008. PMID: 18778374
-
Synergism and postantibiotic effect of tobramycin and Melaleuca alternifolia (tea tree) oil against Staphylococcus aureus and Escherichia coli.Phytomedicine. 2010 Apr;17(5):317-22. doi: 10.1016/j.phymed.2009.07.008. Epub 2009 Aug 20. Phytomedicine. 2010. PMID: 19699074
-
Comparison of chitosan and SLN nano-delivery systems for antibacterial effect of tea tree (Melaleuca alternifolia) oil against P. aeruginosa and S. aureus.Lett Appl Microbiol. 2023 Nov 1;76(11):ovad130. doi: 10.1093/lambio/ovad130. Lett Appl Microbiol. 2023. PMID: 37989849
-
In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.Clin Microbiol Infect. 2007 Jun;13 Suppl 2:17-24. doi: 10.1111/j.1469-0691.2007.01722.x. Clin Microbiol Infect. 2007. PMID: 17488372 Review.
-
Antimicrobial peptides: evolving soldiers in the battle against drug-resistant superbugs.Mol Biol Rep. 2025 Apr 28;52(1):432. doi: 10.1007/s11033-025-10533-z. Mol Biol Rep. 2025. PMID: 40293554 Review.
Cited by
-
Short-Term Probiotic Administration Increases Fecal-Anti Candida Activity in Healthy Subjects.Microorganisms. 2019 Jun 3;7(6):162. doi: 10.3390/microorganisms7060162. Microorganisms. 2019. PMID: 31163660 Free PMC article.
-
Synergistic Inhibition of Methicillin-Resistant Staphylococcus aureus (MRSA) by Melaleuca alternifolia Chell (Tea Tree) and Eucalyptus globulus Labill. Essential Oils in Association with Oxacillin.Antibiotics (Basel). 2023 May 3;12(5):846. doi: 10.3390/antibiotics12050846. Antibiotics (Basel). 2023. PMID: 37237749 Free PMC article.
-
Disease spectrum of patients with hospital-acquired multidrug-resistant organism infections in the intensive care unit: a retrospective study.Front Microbiol. 2025 May 19;16:1568615. doi: 10.3389/fmicb.2025.1568615. eCollection 2025. Front Microbiol. 2025. PMID: 40458710 Free PMC article.
-
Recent advances to combat ESKAPE pathogens with special reference to essential oils.Front Microbiol. 2022 Dec 6;13:1029098. doi: 10.3389/fmicb.2022.1029098. eCollection 2022. Front Microbiol. 2022. PMID: 36560948 Free PMC article. Review.
-
Tea Tree Oil: Properties and the Therapeutic Approach to Acne-A Review.Antioxidants (Basel). 2023 Jun 12;12(6):1264. doi: 10.3390/antiox12061264. Antioxidants (Basel). 2023. PMID: 37371994 Free PMC article. Review.
References
-
- Munoz-Price L.S., Poirel L., Bonomo R.A., Schwaber M.J., Daikos G.L., Cormican M., Cornaglia G., Garau J., Gniadkowski M., Hayden M.K., et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect. Dis. 2013;13:785–796. doi: 10.1016/S1473-3099(13)70190-7. - DOI - PMC - PubMed
-
- Zhao W.H., Hu Z.Q., Hara Y., Shimamura T. Inhibition of penicillinase by epigallocatechin gallate resulting in restoration of antibacterial activity of penicillin against penicillinase-producing Staphylococcus aureus. Antimicrob. Agents Chemother. 2002;46:2266–2268. doi: 10.1128/AAC.46.7.2266-2268.2002. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical